A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...
The combination of ribociclib and letrozole achieved a 30.6% objective response rate and 84% clinical benefit rate in ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
Explore how aggressive breast cancer evades immune defences and discover potential treatment strategies with our latest ...
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
At the core of CTOAM's work, Morand explains, is a precision oncology process that integrates multiple diagnostic tools into ...
Sweeney won the Top Presentation Award for his talk titled, “The SUMO Balancing Act: Insights into Cellular Robustness from ...
The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...
A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...
A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...
In the current study, published today in the journal Nature Biotechnology, Cheng and his colleagues created an exosome system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback